Fennec Pharmaceuticals Reports Strong 2023 Growth

Fennec Pharmaceuticals (TSE:FRX) has released an update. Fennec Pharmaceuticals saw strong fiscal performance with $21.3 million in full-year 2023 ...

Related Keywords

,Fennec Pharmaceuticals ,